USNA Usana Health Sciences Inc

  1. Stocks
  2. Consumer Defensive
  3. NYSE: USNA

Price (delayed)

$48.06

Market cap

$919.38M

P/E Ratio

15.55

Dividend/share

N/A

EPS

$3.09

Enterprise value

$612.3M

USANA prides itself in providing consumers the highest quality nutritional products in the world. From its award-winning supplements to its innovative skincare line, USANA has proven for more than 25 ...

Highlights
The quick ratio has grown by 36% YoY and by 3.4% from the previous quarter
The price to earnings (P/E) is 13% lower than the last 4 quarters average of 17.9 and 3.4% lower than the 5-year quarterly average of 16.1
The EPS has contracted by 23% YoY and by 6% from the previous quarter
USNA's net income is down by 22% year-on-year and by 6% since the previous quarter
Sector: Consumer Defensive
Industry: Household & Personal Products
Website: http://www.usana.com
Peers: NATR NUS PRPH MTEX

Key stats

What are the main financial stats of USNA
Market
Shares outstanding
19.13M
Market cap
$919.38M
Enterprise value
$612.3M
Valuations
Price to earnings (P/E)
15.55
Price to book (P/B)
1.97
Price to sales (P/S)
1
EV/EBIT
6.2
EV/EBITDA
5.12
EV/Sales
0.66
Earnings
Revenue
$927.89M
EBIT
$98.79M
EBITDA
$119.57M
Free cash flow
$74.64M
Per share
EPS
$3.09
Free cash flow per share
$3.88
Book value per share
$24.37
Revenue per share
$48.21
TBVPS
$28.83
Balance sheet
Total assets
$601.15M
Total liabilities
$130.75M
Debt
$0
Equity
$470.39M
Working capital
$277.9M
Liquidity
Debt to equity
0
Current ratio
3.47
Quick ratio
2.73
Net debt/EBITDA
-2.57
Margins
EBITDA margin
12.9%
Gross margin
80.5%
Net margin
6.4%
Operating margin
9.9%
Efficiency
Return on assets
9.9%
Return on equity
13.1%
Return on invested capital
75.7%
Return on capital employed
20.2%
Return on sales
10.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

USNA stock price

How has the Usana Health Sciences stock price performed over time
Intraday
1.69%
1 week
1.91%
1 month
8.15%
1 year
-11.31%
YTD
-9.66%
QTD
-18%

Financial performance

How have Usana Health Sciences's revenue and profit performed over time
Revenue
$927.89M
Gross profit
$747.08M
Operating income
$91.4M
Net income
$59.82M
Gross margin
80.5%
Net margin
6.4%
The operating income has declined by 22% year-on-year and by 5% since the previous quarter
USNA's net income is down by 22% year-on-year and by 6% since the previous quarter
USNA's net margin is down by 14% YoY and by 4.5% from the previous quarter
Usana Health Sciences's operating margin has decreased by 12% YoY and by 2.9% QoQ

Growth

What is Usana Health Sciences's growth rate over time

Valuation

What is Usana Health Sciences stock price valuation
USNA P/E details
P/E
15.55
P/B
1.97
P/S
1
EV/EBIT
6.2
EV/EBITDA
5.12
EV/Sales
0.66
The EPS has contracted by 23% YoY and by 6% from the previous quarter
The price to earnings (P/E) is 13% lower than the last 4 quarters average of 17.9 and 3.4% lower than the 5-year quarterly average of 16.1
USNA's P/B is 52% below its 5-year quarterly average of 4.1 and 21% below its last 4 quarters average of 2.5
The company's equity rose by 8% YoY
USNA's price to sales (P/S) is 33% less than its 5-year quarterly average of 1.5 and 17% less than its last 4 quarters average of 1.2
USNA's revenue is down by 11% year-on-year and by 2.1% since the previous quarter

Efficiency

How efficient is Usana Health Sciences business performance
The ROE has contracted by 28% YoY and by 7% from the previous quarter
Usana Health Sciences's ROA has decreased by 24% YoY and by 7% from the previous quarter
The company's return on invested capital fell by 24% YoY and by 7% QoQ
The ROS has contracted by 6% YoY

Dividends

What is USNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for USNA.

Financial health

How did Usana Health Sciences financials performed over time
The quick ratio has grown by 36% YoY and by 3.4% from the previous quarter
The current ratio has increased by 30% YoY
USNA's debt is 100% less than its equity
The company's equity rose by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.